Human epidermal growth factor receptor
The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study
11
Prognostic significance of Human epidermal growth factor receptor 2 expression in patients with resectable gastric adenocarcinoma
9
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients
10
Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France : African women exhibit a mutational spectrum more similar to Asians than to Caucasians
13
The progress of targeted therapy in advanced gastric cancer
8
Triple-negative breast cancer: new perspectives for targeted therapies
17
6100.pdf
46
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
8
New developments in the treatment of HER2-positive breast cancer
12
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer
13
Mutations in the phosphatidylinositol 3 kinase pathway: role in tumor progression and therapeutic implications in breast cancer
12
Metastasizing Maxillary Ameloblastoma: Report of a Case with Molecular Characterization
7
Prognostic Implications of ER, PR and HER2/Neu Protein Expression in a Cohort of Breast Carcinoma
6
In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features
51
Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response
13
Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
12
Does consuming isoflavones reduce or increase breast cancer risk?
5
EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis
9
Design, Synthesis and Anticancer Screening of Novel Piperidine ydroxamate as HDAC Inhibitors.
105
Prognostic value of <em>EGFR</em> and <em>KRAS</em> in resected non-small cell lung cancer: a systematic review and meta-analysis
12